newsfilter
← Latest News
PR Newswire·

Cellect Biotechnology Receives Approval for U.S. Clinical Trial

Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology to enable the functional selection of stem cells, has received...